Anavex Life Sciences Corp (AVXL)

[seventhwave]

Cassava anyone?

Cassava Sciences, Inc., a clinical-stage drug development company, develops drugs for nervous system disorders. The company's lead therapeutic product candidate PTI-125, a small molecule drug that is in Phase II clinical trial for the treatment of Alzheimer's disease. It is also developing PTI-125Dx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
(FYI $PTIE's Remoxy was a multi-part drama that played out over years...)

Whopping $23mm mkt. cap!

2H2019: P2a study (safety, tolerability, PK & biomarker validation) with PTI-125 in Alzheimer's Disease

$SAVA H.C. Wainwright starts Buy with $3 PT. "The analyst sees "unique" disease-modifying potential of PTI-125, the company's Phase 2 stage drug candidate for Alzheimer's disease., saying it demonstrates potential to restore dysfunctional brain cell signaling."

Not a very imaginative name for a co. pursuing Alz. Healthy short.